Moreover, the addition of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, to conventional therapy in patients with severe congestive HF reduces mortality and improves symptoms [8,9], indicating that overproduction of Ang II after RAS activation has harmful effects in HF pathology. This evidence concerns the gene AGT and hydrops fetalis.